Evidence map›Paper›PMID 36625746›Full record

ArticleRadiology2023

Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.

Danalyn Byng, Samantha M Thomas, Christel N Rushing, Thomas Lynch, Anne McCarthy, Amanda B Francescatti, Elizabeth S Frank, Ann H Partridge, Alastair M Thompson, Valesca P Retèl and 5 more

Open access · greenAbstract read
In one paragraph

Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Danalyn ByngFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-8754-0530
Samantha M ThomasFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-1561-9303
Christel N RushingFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).
Thomas LynchFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0003-0267-7456
Anne McCarthyFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0003-0062-0878
Amanda B FrancescattiFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-3099-4726
Elizabeth S FrankFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-1823-6455
Ann H PartridgeFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).
Alastair M ThompsonFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).
Valesca P RetèlFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-5624-3234
Wim H van HartenFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0001-9580-0489
Lars J GrimmFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-3865-3352
Terry HyslopFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).
E Shelley HwangFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-8571-1148
Marc D RyserFrom the Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands (D.B., V.P.R., W.H.v.H.); Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, the Netherlands (D.B., V.P.R., W.H.v.H.); Duke Cancer Institute Biostatistics Shared Resource (S.M.T., C.N.R., T.H.) and Department of Mathematics (M.D.R.), Duke University, Durham, NC; Department of Biostatistics and Bioinformatics (S.M.T., T.H.), Division of Surgical Sciences, Department of Surgery (T.L., E.S.H.), Department of Radiology (L.J.G.), and Department of Population Health Sciences (M.D.R.), Duke University Medical Center, 215 Morris St, Durham, NC 27701; Cancer Programs, American College of Surgeons, Chicago, Ill (A.M., A.B.F.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass (E.S.F., A.H.P.); and Department of Surgery, Baylor College of Medicine, Houston, Tex (A.M.T.).ORCID 0000-0002-4990-0849
Duke University · USUniversity of Twente · NLDana-Farber Cancer Institute · USDuke Medical Center · USBaylor College of Medicine · US

Funding

The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer RiskR00CA207872 · NCI · DUKE UNIVERSITY · PI RYSER, MARC · 2018 to 2020
$746k
NCI NIH HHS R00 CA207872
6 · The paper itself

Abstract

Background Guidelines recommend annual surveillance imaging after diagnosis of ductal carcinoma in situ (DCIS). Guideline adherence has not been characterized in a contemporary cohort. Purpose To identify uptake and determinants of surveillance imaging in women who underwent treatment for DCIS. Materials and Methods A stratified random sample of women who underwent breast-conserving surgery for primary DCIS between 2008 and 2014 was retrospectively selected from 1330 facilities in the United States. Imaging examinations were recorded from date of diagnosis until first distant recurrence, death, loss to follow-up, or end of study (November 2018). Imaging after treatment was categorized into 10 12-month periods starting 6 months after diagnosis. Primary outcome was per-period receipt of asymptomatic surveillance imaging (mammography, MRI, or US). Secondary outcome was diagnosis of ipsilateral invasive breast cancer. Multivariable logistic regression with repeated measures and generalized estimating equations was used to model receipt of imaging. Rates of diagnosis with ipsilateral invasive breast cancer were compared between women who did and those who did not undergo imaging in the 6-18-month period after diagnosis using inverse probability-weighted Kaplan-Meier estimators. Results A total of 12 559 women (median age, 60 years; IQR, 52-69 years) were evaluated. Uptake of surveillance imaging was 75% in the first period and decreased over time (

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingFemaleHumansMammographyMastectomy, SegmentalMiddle AgedRetrospective StudiesUnited States

Identifiers

PMID36625746
PMCPMC10068891
OpenAlexW4315436159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.